Skip to main content
. 1998 Apr;66(4):1648–1653. doi: 10.1128/iai.66.4.1648-1653.1998

FIG. 5.

FIG. 5

IEM101(pTETnir15) persistence in vivo. BALB/c mice received intranasally 108 CFU of IEM101(pTETnir15) (dose indicated by arrow on y axis); the presence of bacteria in the mouse trachea was assessed after 2, 24, and 72 h, with three animals sacrificed per time point. Bacterial counts were performed on TCBS agar plates, with (TCBS-Ap) or without (TCBS) ampicillin. Results are shown as means + standard deviations (error bars) of log10 CFU/organ.